ID T24T SL2 AC CVCL_RN64 SY SL2 DR cancercelllines; CVCL_RN64 DR Wikidata; Q54971475 RX PubMed=19147813; RX PubMed=29732388; CC Population: Caucasian; Swedish. CC Characteristics: Produced by passage of the parent cell line through nude mice. CC Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line). CC Omics: Transcriptome analysis by microarray. CC Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255. DI NCIt; C4912; Bladder carcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_RN63 ! T24T SL1 SX Female AG 82Y CA Cancer cell line DT Created: 05-03-18; Last updated: 19-12-24; Version: 12 // RX PubMed=19147813; DOI=10.2353/ajpath.2009.080538; PMCID=PMC2630547; RA Smith S.C., Nicholson B., Nitz M.D., Frierson H.F. Jr., Smolkin M., RA Hampton G.M., El-Rifai W., Theodorescu D.; RT "Profiling bladder cancer organ site-specific metastasis identifies RT LAMC2 as a novel biomarker of hematogenous dissemination."; RL Am. J. Pathol. 174:371-379(2009). // RX PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350; RA Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.; RT "Systematic review: characteristics and preclinical uses of bladder RT cancer cell lines."; RL Bladder Cancer 4:169-183(2018). //